Several recent studies have shown that EIF4A3 promotes tumor growth in multiple human cancers such as glioblastoma, hepatocellular carcinoma, pancreatic cancer, and ovarian cancer. This evidence concerns the gene EIF4A3 and hepatocellular carcinoma.